Effectiveness of Blood Flow Restriction in Postoperative Rehabilitation for Anterior Cruciate Ligament Injuries. A Pilot Study.
Launched by UNIVERSITY OF VALENCIA · Dec 30, 2024
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a treatment called Blood Flow Restriction (BFR) therapy when combined with standard rehabilitation after surgery to repair the anterior cruciate ligament (ACL) in the knee. The researchers want to find out if this combination helps patients recover better, become stronger, and get back to their normal activities faster compared to just doing the standard rehabilitation alone.
To participate in the study, you need to be between 18 and 45 years old and have recently had ACL reconstruction surgery. Unfortunately, if you have certain health issues like heart problems, severe metabolic disorders, or complications from surgery, you won’t be eligible. If you join the study, you'll follow the rehabilitation plan assigned to you and will be checked before and after to see how well you’re recovering. This trial is currently looking for participants, and it aims to help improve recovery for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged between 18 and 45 years.
- • Patients who have undergone anterior cruciate ligament (ACL) reconstruction surgery
- Exclusion Criteria:
- • Cardiovascular comorbidities
- • Severe metabolic disorders or postoperative complications
- • Previous joint disorders requiring surgery on the affected leg
- • Pregnancy
- • Coagulation disorders
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported